Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Myelodysplastic Syndromes Presenting with Isolated Thrombocytopenia: A Less Aggressive Form of Presentation and with Better Prognosis

Marie Solange Flores-Moran, Leonor Arenillas, Ana Ferrer, Felix Lopez-Cadenas, Sara Garcia-Avila, Concepción Fernández, Antonio Salar, Xavier Calvo

Blood (2022) 140 (Supplement 1): 6960–6961.

DOI: https://doi.org/10.1182/blood-2022-167567

Published: 2022

Journal Articles

Assessment of Dysgranulopoiesis By Optical Cytology Compared to Distribution of Monocyte Subsets By Flow Cytometry in Peripheral Blood for Predicting the Diagnosis of CMML

David Roman-Bravo, Leonor Arenillas, Aylin Vasquez, Lourdes Florensa, Beatriz Costan, Rosa Navarro, Martina Karasiewicz, Sara Garcia-Avila, Felix Lopez-Cadenas, Marta Salido, Anna Puiggros, Blanca Espinet, Ana Ferrer, Xavier Calvo

Blood (2022) 140 (Supplement 1): 12347–12348.

DOI: https://doi.org/10.1182/blood-2022-166229

Published: 2022

Journal Articles

Clonal Dynamics of JAK2 V617F and Non-Driver Mutations in Polycythemia Vera and Essential Thrombocythemia Patients Receiving Hydroxyurea Therapy

Lierni Fernández-Ibarrondo, Joan Gibert, Concepción Fernández-Rodríguez, Laura Camacho, Anna Angona, Marcio Andrade, Nieves Garcia-Gisbert, Leonor Arenillas, Patricia Vélez, Raquel Longarón, Ramon Diez-Feijoo, Antonio Salar, Carles Besses, Beatriz Bellosillo

Blood (2021) 138 (Supplement 1): 3623.

DOI: https://doi.org/10.1182/blood-2021-150491

Published: 2021

Journal Articles

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Nieves Garcia-Gisbert, Brayan Merchan, Sara Garcia-Avila, Marta Salido, Concepción Fernández-Rodríguez, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Marta Lafuente, Raquel Longarón, Blanca Espinet, Patricia Vélez, Marcio M Andrade-Campos, Ramon M. Pujol, Leonor Arenillas, Xavier Calvo, Carles Besses, Antonio Salar, Beatriz Bellosillo

Blood (2021) 138 (Supplement 1): 2599.

DOI: https://doi.org/10.1182/blood-2021-148297

Published: 2021

Journal Articles

Multiple TET2 Mutations As a New Biological Clue for Differentiating Oligomonocytic Chronic Myelomonocytic Leukemia from Myelodysplastic Syndromes

Nieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, Juan José Rodríguez-Sevilla, Brayan Merchan, Sara Garcia-Avila, Concepción Fernández-Rodríguez, Joan Gibert, Antonio Salar, Beatriz Bellosillo, Ana Ferrer, Xavier Calvo

Blood (2021) 138 (Supplement 1): 1530.

DOI: https://doi.org/10.1182/blood-2021-152674

Published: 2021

Journal Articles

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

David Roman-Bravo, Leonor Arenillas, Maria Teresa Asensi, Nieves Garcia-Gisbert, Juan Jose Rodriguez-Sevilla, Brayan Merchan, Sara García Ávila, Beatriz Bellosillo, Concepción Fernández-Rodríguez, Lourdes Florensa, Ana Ferrer, Xavier Calvo

Blood (2021) 138 (Supplement 1): 1533.

DOI: https://doi.org/10.1182/blood-2021-146447

Published: 2021

Journal Articles

Early Immune Profile Assessment By Flow Cytometry Predicts Severe COVID-19 Pneumonia

Abora Rial-Villavecchia, Maria Teresa Asensi, Carme Giménez-Argente, Joan Gómez-Junyent, Juan Jose Rodriguez-Sevilla, Leonor Arenillas, Ana Ferrer, Eloi García-Vives, Jaime Rodriguez-Morera, Jade Soldado-Folgado, Xavier Calvo

Blood (2021) 138 (Supplement 1): 4197.

DOI: https://doi.org/10.1182/blood-2021-151282

Published: 2021

Journal Articles

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Marcio M Andrade-Campos, MD PhD, Lierni Fernández-Ibarrondo, Joan Gibert, PhD, Concepción Fernández, Brayan Merchan, MD, Nieves García Gisbert, BSc, Laura Camacho, Leonor Arenillas, MD PhD, Sara García Ávila, MD, Raquel Longarón, Antonio Salar, MD PhD, Carles Besses, MD PhD, Beatriz Bellosillo, PhD

Blood (2020) 136 (Supplement 1): 13–14.

DOI: https://doi.org/10.1182/blood-2020-142705

Published: 2020

Journal Articles

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Blood (2019) 134 (Supplement_1): 2687.

DOI: https://doi.org/10.1182/blood-2019-131733

Published: 2019

Journal Articles

Clinical Interest of LMO2 Testing in Aggressive Large B-Cell Lymphomas

Luis Colomo, Ivonne Vazquez, Natalia Papaleo, Marta Salido, Anna Puiggros, Blanca Espinet, Maria Rodriguez-Rivera, Ramon Diez-Feijoo, Blanca Sanchez-Gonzalez, Antonio Salar, Ana Ferrer, Leonor Arenillas, Marcio Andrade Campos, MD PhD, Xavier Calvo

Blood (2019) 134 (Supplement_1): 2899.

DOI: https://doi.org/10.1182/blood-2019-125717

Published: 2019

Journal Articles

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Xavier Calvo, MD PhD, Ivonne Parraga, Fellow, Nieves Garcia-Gisbert, MSc, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade Campos, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD

Blood (2019) 134 (Supplement_1): 5437.

DOI: https://doi.org/10.1182/blood-2019-130499

Published: 2019

Journal Articles

Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment

David Roman, MD, Leonor Arenillas, MD PhD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Marta Salido, PhD, Puiggros Anna, Blanca Espinet, PhD, Lluís Colomo, MD PhD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Xavier Calvo, MD PhD

Blood (2019) 134 (Supplement_1): 4262.

DOI: https://doi.org/10.1182/blood-2019-128768

Published: 2019

Journal Articles

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Xavier Calvo, MD PhD, Nieves Garcia-Gisbert, MSc, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD

Blood (2019) 134 (Supplement_1): 4266.

DOI: https://doi.org/10.1182/blood-2019-130445

Published: 2019

Journal Articles

Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids

Nieves Garcia-Gisbert, MSc, Lierni Fernández-Ibarrondo, Concepción Fernández-Rodríguez, Laura Camacho, Anna Angona, MD PhD, Joan Gibert, PhD, Xavier Calvo, MD PhD, Leonor Arenillas, MD PhD, Raquel Longarón, Marcio Andrade, MD PhD, Antonio Salar, MD PhD, Carles Besses, MD PhD, Beatriz Bellosillo, PhD

Blood (2019) 134 (Supplement_1): 2953.

DOI: https://doi.org/10.1182/blood-2019-123003

Published: 2019

Journal Articles

Diagnostic Utility of Flow Cytometric Immunophenotyping in Chronic Myelomonocytic Leukemia

Leonor Arenillas, MD PhD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca Romero, MD, Anna Puiggros, PhD, Marta Salido, PhD, Blanca Espinet, PhD, Anna Angona, MD PhD, Ana Ferrer, MD PhD, Carme Pedro, MD, Xavier Calvo, MD

Blood (2018) 132 (Supplement 1): 5526.

DOI: https://doi.org/10.1182/blood-2018-99-119689

Published: 2018

Journal Articles

Immunophenotypic Characteristics of Olygomonocytic Chronic Myelomonocytic Leukemia Support Its Diagnosis As a Distinctive Entity in the Continuum of Chronic Myelomonocytic Leukemia

Xavier Calvo, MD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca Romero, MD, Anna Puiggros, PhD, Marta Salido, PhD, Blanca Espinet, PhD, Anna Angona, MD PhD, Ana Ferrer, MD PhD, Carme Pedro, MD, Leonor Arenillas, MD PhD

Blood (2018) 132 (Supplement 1): 5520.

DOI: https://doi.org/10.1182/blood-2018-99-119906

Published: 2018

Journal Articles

The Use of Immunosuppressive Therapy (IST) in Patients with the Myelodysplastic Syndromes (MDS): Clinical Outcomes and Their Predictors in a Large International Patient Cohort

Blood (2017) 130 (Supplement 1): 422.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.422.422

Published: 2017

Journal Articles

Considering Bone Marrow Blasts from Nonerythroid Cellularity Improves the Prognostic Evaluation of MDS in the Context of IPSS-R and Permits a Better Risk Assessment of MDS Patients Classified into the Intermediate Risk Category

Blood (2016) 128 (22): 3185.

DOI: https://doi.org/10.1182/blood.V128.22.3185.3185

Published: 2016

Journal Articles

Considering Bone Marrow Blasts from Nonerythroid Cells Improves the Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts

Blood (2016) 128 (22): 1991.

DOI: https://doi.org/10.1182/blood.V128.22.1991.1991

Published: 2016

Journal Articles

Myelodysplastic Syndromes (MDS) with Erythroid Hyperplasia: Enumerating Blasts from Non-Erythroid Cell Compartment Improves the Risk Stratification of MDS with Excess of Blasts

Leonor Arenillas, MD, Xavier Calvo, MD, Mar Tormo, MD PhD, David Valcárcel, MD PhD, Elisa Luño, MD PhD, Esther Alonso, MD, María Consuelo Cañizo, MD PhD, Fernando Ramos, MD PhD MPH, Carmen Pedro, MD PhD, Beatriz Arrizabalaga, MD, Alicia Bailén, MD, José María Raya, MD, María Teresa Ardanaz, MD, Guillermo Sanz, MD PhD, Lourdes Florensa, MD PhD

Blood (2015) 126 (23): 2894.

DOI: https://doi.org/10.1182/blood.V126.23.2894.2894

Published: 2015

NARROW

Myelodysplastic Syndromes Presenting with Isolated Thrombocytopenia: A Less Aggressive Form of Presentation and with Better Prognosis

Assessment of Dysgranulopoiesis By Optical Cytology Compared to Distribution of Monocyte Subsets By Flow Cytometry in Peripheral Blood for Predicting the Diagnosis of CMML

Clonal Dynamics of JAK2 V617F and Non-Driver Mutations in Polycythemia Vera and Essential Thrombocythemia Patients Receiving Hydroxyurea Therapy

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Multiple TET2 Mutations As a New Biological Clue for Differentiating Oligomonocytic Chronic Myelomonocytic Leukemia from Myelodysplastic Syndromes

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

Early Immune Profile Assessment By Flow Cytometry Predicts Severe COVID-19 Pneumonia

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Clinical Interest of LMO2 Testing in Aggressive Large B-Cell Lymphomas

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids

Diagnostic Utility of Flow Cytometric Immunophenotyping in Chronic Myelomonocytic Leukemia

Immunophenotypic Characteristics of Olygomonocytic Chronic Myelomonocytic Leukemia Support Its Diagnosis As a Distinctive Entity in the Continuum of Chronic Myelomonocytic Leukemia

The Use of Immunosuppressive Therapy (IST) in Patients with the Myelodysplastic Syndromes (MDS): Clinical Outcomes and Their Predictors in a Large International Patient Cohort

Considering Bone Marrow Blasts from Nonerythroid Cellularity Improves the Prognostic Evaluation of MDS in the Context of IPSS-R and Permits a Better Risk Assessment of MDS Patients Classified into the Intermediate Risk Category

Considering Bone Marrow Blasts from Nonerythroid Cells Improves the Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts

Myelodysplastic Syndromes (MDS) with Erythroid Hyperplasia: Enumerating Blasts from Non-Erythroid Cell Compartment Improves the Risk Stratification of MDS with Excess of Blasts

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only